Mipharm S.p.A. operates as a prominent supplier in the pharmaceutical industry, specialising in contract development and manufacturing (CDMO). Founded in January 1998, the company emerged from a spin-off of the manufacturing site located in Milan, previously owned by Sandoz. Mipharm has established itself as one of the most valuable third-party manufacturing and new product development sites in Italy, boasting four FDA approvals for various formulations. With significant investments geared towards enhancing its manufacturing standards, Mipharm offers a broad spectrum of products and pharmaceutical forms, including oral solids, oral liquids, nasal sprays, creams, suppositories, and oral potent drugs.

Services include:
- Contract Development and Manufacturing (CDMO)
- Finished Dosage Forms
- Regulatory Services
- Containment
- Solid Dosage
- Non Sterile Dosage
- Packaging

Mipharm S.p.A remains committed to delivering high-quality pharmaceutical manufacturing services and invites those interested to find more information at mipharm.it.